博客
5 Ways to Keep Your Stem Cells Healthy: What 2026 Science Says
Your body's repair system ages with you — but exercise, sleep, fasting, diet, and stress management all have measurable effects on stem cell function. Here is what the latest research says.
Oct 19, 2026
MSC Therapy for Atopic Dermatitis: Meta-Analysis of RCTs and Phase 2 Data Reveal
A 2026 meta-analysis pools 236 patients across 5 trials, and a 114-patient Phase 2 RCT shows MSC therapy achieves EASI-75 in 24% of severe AD patients. Exosome hydrogel delivery and batch consistency data now address the…
Oct 18, 2026
Stem Cell Therapy for Low Back Pain: What the 2025–2026 Clinical Trials Actually Show
Three major clinical trials — including a 404-patient 3-year study — are finally giving us real data on whether MSC therapy works for chronic low back pain and degenerative disc disease. Here's what the evidence says, in…
Oct 17, 2026
MSC Therapy for Parkinson’s Disease: What Randomized Trials and Comprehensive Reviews Reveal
Multiple 2026 clinical trials and reviews show mesenchymal stem cell therapy is safe and feasible for Parkinson's disease — but what do the actual data say about efficacy, dosing, and what comes next?
Oct 16, 2026
MSC Therapy for Pediatric Acute GvHD: From FDA Approval to Next-Generation Approaches
The first FDA-approved MSC therapy (Ryoncil) ended a 20-year drought for cell-based products in the US. New real-world data from 139 children and next-generation platforms are reshaping how clinicians treat steroid-refra…
Oct 15, 2026
Can Stem Cell Therapy Help Children with Autism? What 2026 Research Shows
A double-blind RCT shows cord blood stem cells improved social cognition in children with autism. Here's what parents need to know about the latest research, safety data, and treatment process.
Oct 14, 2026
MSC Therapy for Chronic Kidney Disease: What the 2025 Evidence Shows
A 2025 meta-analysis of 52 studies, real-world Taiwan data, and Mayo Clinic intraarterial delivery results — what nephrologists need to know about MSCs and CKD.
Oct 14, 2026
MSC Therapy for Pulmonary Fibrosis: 2026 Preclinical and Clinical Evidence Review
A medical review of MSC-based and MSC-derived EV therapies for idiopathic pulmonary fibrosis, covering meta-analysis data, immune-cloaked cell engineering, nebulized exosome delivery, gut-lung axis mechanisms, and active…
Sep 23, 2026
MSC Therapy for Ischemic Stroke: What a 2026 Umbrella Review and Network Meta-Analysis of 1,006 Patients Reveal
The 2026 evidence base for mesenchymal stem cell therapy in ischemic stroke includes a 26-study umbrella review and an 18-RCT network meta-analysis of 1,006 patients. MSCs were the only cell type to significantly reduce …
Sep 7, 2026
为什么你的干细胞在40岁后会减缓活动(以及科学界正在如何应对这一问题)
Research shows MSC activity drops 40% by age 50. Learn what changes inside aging cells and three emerging therapies showing real results in 2026 clinical trials.
Sep 4, 2026
MSC临床试验:ISCT都柏林会议揭示了半月板修复、线粒体移植和细胞来源方面的信息
A medical review of MSC clinical trials 2026: key evidence from ISCT Dublin, a Japanese phase III synovial-MSC meniscal repair trial, bone marrow vs cord tissue OA data, and mitochondrial EV mechanisms.
Aug 28, 2026
呼吸更顺畅:干细胞疗法如何改变泰国慢性阻塞性肺病的治疗
Our Bangkok clinic explores how MSC therapy is helping COPD patients breathe easier — reducing inflammation, reactivating lung stem cells, and improving quality of life.
Aug 28, 2026
Page 1 of 13 — 156 posts